Supplier of scientific instrumentation and software services
8 AI-extracted insights from 7 sources — podcasts, YouTube channels, and X/Twitter accounts.
Not enough scored insights about Thermo Fisher Scientific Inc. in the last 30 days yet.
Sources are generally bullish on Thermo Fisher Scientific Inc. (TMO), highlighting institutional buying and technical recovery following a prior bear cycle. (3 of 3 sources bullish/slightly bullish)
AI-generated summary. Not investment advice. Learn more.
The 6 sources with the most insights about Thermo Fisher Scientific Inc. on Kazuha.
AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.
Demonstrating technical bottoming patterns and early signs of institutional accumulation after an extended bear cycle.
One of the top-bought blue-chip stocks by large funds in Q2.
Signed a $2.3 million letter of intent with Precigenetics involving 11 chips as the beginning of a scoped collaboration.
Traded up aggressively by 6% to 9%, prompting the speaker to consider potential short setups after initial small short testing.
Partnering with OpenAI as part of its aggressive push into enterprise-sector high-margin contracts.
Diagnostic play expected to benefit from testing scale-up during a health crisis.
Partnering with NVIDIA to use AI to transform drug discovery, which is a significant positive development.
Demonstrating technical bottoming patterns and early signs of institutional accumulation after an extended bear cycle.
One of the top-bought blue-chip stocks by large funds in Q2.
Signed a $2.3 million letter of intent with Precigenetics involving 11 chips as the beginning of a scoped collaboration.
Traded up aggressively by 6% to 9%, prompting the speaker to consider potential short setups after initial small short testing.
Partnering with OpenAI as part of its aggressive push into enterprise-sector high-margin contracts.
Diagnostic play expected to benefit from testing scale-up during a health crisis.
Partnering with NVIDIA to use AI to transform drug discovery, which is a significant positive development.
Other assets that creators frequently mention in the same content as Thermo Fisher Scientific Inc..
The most active sources covering Thermo Fisher Scientific Inc. (TMO) on Kazuha are @realmartinshkreli, amitisinvesting, bubbleboi, Steve Eisman, All-In Podcast, LLC. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.
Kazuha has indexed 8 AI-extracted insights about Thermo Fisher Scientific Inc. (TMO) from 7 different sources. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.
Creators covering Thermo Fisher Scientific Inc. (TMO) most frequently also discuss GOOGL, AMZN, MSFT, MU, VST. See the "Discussed alongside" section above for full asset pages.